Characterization of the pre-metastatic niche in lymph node, in experimental and clinical settings by Noël, Agnès et al.
Characterization of the pre-metastatic niche in 
lymph node, in experimental and clinical settings 
A.  Noel1, C. Balsat1, M. Garcia-Caballero1, M. Vandevelde1, S. Blacher1 and F Kridelka2 
BACKGROUND	  AND	  OBJECTIVES	  
1Laboratory	  of	  Tumor	  and	  Development	  Biology	  (GIGA-­‐Cancer),	  University	  of	  Liège,	  Pathology	  Tower	  (B23),	  B-­‐4000	  Liège,	  Belgium.	  2Department	  of	  Pathology,	  Laboratory	  of	  Experimental	  Pathology,	  GIGA-­‐Cancer,	  
University	  of	  Liege,	  Liege,	  Belgium.	  3Department	  of	  Obstetrics	  and	  Gynecology,	  Hospital	  of	  la	  Citadelle,	  Liège,	  Belgium.	  4Department	  of	  Obstetrics	  and	  Gynecology,	  CHU	  of	  Liège,	  B-­‐4000	  Liège,	  Belgium.	  
Clinical	  issue:	   	  Lymph	  node	  status	  (N+/N-­‐)	  is	  a	  strong	  prognos;c	  factor	  of	  paQent’s	  cancer	  speciﬁc	  survival	  which	  is	  widely	  used	  to	  guide	  therapeuQc	  decisions.	  A	  pelvic	  
and/or	  para-­‐aorQc	  lymph	  node	  dissecQon	  remains	  mandatory	  in	  order	  to	  conﬁrm	  the	  histological	  nodal	  status.	  However,	  this	  surgical	  staging	  is	  associated	  
to	   therapeuQc	  morbidity	   (lymphodema).	  The	   laXer	   risk	   is	  parQcularly	  marked	  when	  an	  adjuvant	   radiaQon	   therapy	   is	   administrated	  a[er	   the	   surgery	   to	  
paQents	  diagnosed	  N+.	  
Current	  view:	  A	   speciﬁc	  dialogue	  between	   the	  primary	   tumor	  and	   the	   lymph	  node	   leads	   to	   the	   formaQon	  of	  a	   supporQve	  microenvironment	   for	  metastasis,	   the	  pre-­‐
metasta;c	  niche.	  A	  beXer	  understanding	  of	  pre-­‐metastaQc	  modulaQons	  that	  occur	  in	  the	  sen;nel	  lymph	  node	  (SLN),	  the	  ﬁrst	  tumor	  draining	  lymph	  node	  
that	  remains	  the	  iniQal	  site	  of	  tumor	  metastasis	  is	  needed.	  A	  digital	  image	  analysis	  methodology	  assisted	  by	  computer	  was	  used	  to	  determine	  objecQvely	  
whole	  slide	  densiQes	  and	  spaQal	  distribuQons	  of	  immunostained	  structures	  (D2/40+	  lymphaQc	  vessels,	  CD8,	  Foxp3,	  CD20	  and	  PD-­‐1).	  	  
Objec;ves:	   	  We	  aim	  at	  gecng	  new	   insights	   into	   the	   lympha;c	  vessel	  dynamics	  and	   immune	  microenvironment	   in	   the	  senQnel	   lymph	  node	   (SLN)	  on	  human	  early	  
cervical	  cancers	  (FIGO	  stage	  1B1,	  n=50).	  We	  also	  set	  up	  an	  in	  vivo	  model	  reproducing	  the	  pre-­‐metastaQc	  lymphangiogenic	  niche	  in	  lymph	  node.	  	  
Througth	  a	  whole	  slide	  computer-­‐assisted	  method,	  we	  highlight	  the	  presence	  of	  a	  subcapsular	  lymphangiogenesis	  
that	  may	  facilitate	  the	  transport	  of	  tumor	  cells	  	  from	  the	  primary	  tumor	  to	  the	  SLN-­‐.	  In	  addi;on	  to	  the	  presence	  of	  
a	   T	   regulatory	   and	   cytotoxic	   lymphocyte	   rich	  microenvironment	   in	   the	   paracortex	   of	   SLN-­‐	   our	   data	   indicate	   a	  
modula;on	  of	  humoral	  immunity	  (B	  lymphocytes)	  in	  the	  superﬁcial	  cortex,	  which	  is	  associated	  to	  a	  subcapsular	  
lymphangiogenesis.	  All	   together,	  our	  data	  bring	  out	   that,	   in	  addi;on	   to	  provide	  a	  physical	   route	   for	   tumor	   cell	  
dissemina;on,	   lympha;c	  vascular	  network	  could	  play	  a	  role	  in	  the	  modula;on	  of	  the	  humoral	  pro/an;-­‐tumoral	  
immune	  response	  in	  the	  SLN	  prior	  metastasis.	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  lymphangiogenesis	  
A.	  CLINICAL	  RESULTS	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Figure	   1:	   LymphaQc	   vascular	  
network	   characterizaQon.	   (a-­‐f)	  
IllustraQon	   of	   lymphaQc	  
endothelial	   cell	   immunostaining	  
(D2-­‐40,	   brown,	   le[	   column)	   and	  
corresponding	   binary	   image	   of	  
whole	   Qssue	   (right	   column)	   in	  
LN-­‐	  (a	  and	  b),	  SLN-­‐	  (c	  and	  d)	  and	  
N+	   (e	   and	   f).	   The	   subcapsular	  
sinus	  (arrows),	  tumor	  cell	  emboli	  
within	   a	   lymphaQc	   a	   vessel	  
secQon	   (TE	   in	   panel	   e)	   and	  
invading	  tumor	  cells	   (IT,	   in	  panel	  
e)	   are	   highlighted.	   In	   binary	  
images,	   lymphaQc	   vessels	   (red)	  
are	   detected	   on	   whole	   Qssue	  
(grey).	   Clusters	   of	   tumor	   cells	   in	  
N+	  are	   represented	   in	  white.	   (g)	  
LymphaQc	   vessel	   density	  
measured	   on	   whole	   LN-­‐,	   SLN-­‐	  
and	   N+	   Qssues.	   (h)	   Double	  
immunostaining	   of	   lymphaQc	  
endothelial	   cells	   (D2-­‐40,	   pink)	  
and	   proliferaQng	   cells	   (Ki67,	  
brown).	   The	   insert	   shows	   a	  
magniﬁcaQon	   of	   a	   proliferaQng	  
lymphaQc	   vessel	   with	   a	   ki67	  
posiQve	   endothelial	   cells	   (arrow	  
head).	   The	   Qssue	   area,	   in	  which	  
90%	  of	  the	  lymphaQc	  distribuQon	  
are	   meanly	   found	   (grey)	   is	  
represented.	   Scale	   bars	   on	  
immunostained	  Qssues	  represent	  
100µm.	  **p<0.01.	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Figure	   2:	   Analysis	   of	   the	  
immune	   response	   proﬁles	   in	  
LN-­‐	  and	  SLN-­‐.	  (a-­‐b)	  IllustraQon	  
of	   the	   immunostaining	   of	  
CD8+	   T	   lymphocytes	   (a	   and	  
e),	   Foxp3+	   T	   lymphocytes	   (b	  
and	   f),	   CD20+	   B	   lymphocytes	  
(c	  and	  g)	  and	  PD-­‐1+	  germinal	  
center	   (d	   and	   h)	   in	   LN-­‐	   (ﬁrst	  
line)	   and	   SLN-­‐	   (second	   line),	  
(brown).	   	   Inserts	   show	   the	  
immunostaining	  of	  single	  cells	  
at	  a	  higher	  magniﬁcaQon.	  (e-­‐l)	  
Computerized	   quanQﬁcaQon	  
of	   whole	   slide	  
immunostaining.	   DensiQes	   of	  
immunostaining	   (e-­‐h)	   and	  
spaQal	   distribuQon	   analysis	  
from	   Qssue	   edge	   to	   Qssue	  
center	   measured	   in	   LN-­‐	   and	  
SLN-­‐	   (i-­‐l).	   *P<0.05,	   **P<0.01,	  
***P<0.001.	   Scales	   bars	  
represent	  100	  µm.	  
ParacorQcal	   hyperplasia	   (cytotoxic	   and	  
regulatory	  T	  lymphocyte	  accumulaQon)	  	  
Summary:	   A	   subcapsular	  	  
lymphangiogenesis	  (lymphaQc	  vessel	  =	  red)	  
occurs	  prior	  to	  tumor	  cell	  disseminaQon.	  In	  
addiQon	   to	   cytotoxic	   	   and	   regulatory	   T	  
lymphocyte	   accumulaQon	   in	   the	  
paracortex,	   this	   lymphangiogenesis	   is	  
associated	   to	   humoral	   modulaQons:	   A	  
PD-­‐1+	  germinal	  follicle	  (blue)	  accumulaQon	  
in	   the	   superﬁcial	   area,	   structure	   mainly	  
composed	   by	   B	   lymphocytes,	   is	   linked	   to	  
the	   	   presence	   of	   a	   subcapsular	  
lymphangiogenesis.	  
B.	  PRE-­‐CLINICAL	  RESULTS	  
CONCLUSIONS	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